Longitudinal Effect of Luspatercept Treatment on Iron Overload and Iron Chelation Therapy (ICT) in Adult Patients (Pts) with β-Thalassemia in the Believe Trial
Year: 2020
Type: article
Source: Blood
Authors: Olivier Hermine, Maria Domenica Cappellini, Ali T. Taher, Thomas D. Coates, Vip Viprakasit, Ersi Voskaridou, Ashutosh Lal, Hong Keng Liew, Silverio Perrotta, Abderrahim Khelif, Antonis Kattamis, Jeevan K. Shetty, George Zhang, Yu (Olivia) Tian, Dimana Miteva, Tatiana Zinger, Derek Tang, Jay T. Backstrom, John B. Porter
Institutions: Hôpital Necker-Enfants Malades, Inserm, Université Paris Cité, Assistance Publique – Hôpitaux de Paris, Institut des Maladies Génétiques Imagine, University of Milan, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, American University of Beirut Medical Center, University of Southern California, Children's Hospital Los Angeles, Siriraj Hospital, Mahidol University, Laiko General Hospital of Athens, University of California, San Francisco, UCSF Benioff Children's Hospital, Hospital Sultanah Bahiyah, University of Campania "Luigi Vanvitelli", Hôpital Farhat Hached, University of Sousse, National and Kapodistrian University of Athens, Bristol-Myers Squibb (United States), Acceleron Pharma (United States), University College London
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3095054591